AFT Pharmaceuticals Ltd (OTCPK:AFTPF)
$ 0 0 (0%) Market Cap: 205.17 Mil Enterprise Value: - PE Ratio: 25.89 PB Ratio: 3.63 GF Score: 90/100

Half Year 2022 AFT Pharmaceuticals Ltd Earnings Call Transcript

Nov 17, 2021 / 09:00PM GMT
Operator

Thank you for standing by, and welcome to the AFT Pharmaceuticals' 2021 Half Year Results Analyst Briefing. (Operator Instructions)

I would now like to hand the conference over to Hartley Atkinson, CEO. Please go ahead.

Hartley Atkinson
AFT Pharmaceuticals Limited - Founder, CEO, MD & Executive Director

Good. Thank you very much, and welcome, everyone, to the presentation of our half year FY 2022 investor presentation. Now the presentation is on the website. So I'll just be going through that, and I'll read out the page numbers as I go.

So looking through Page #2, is the standard disclaimer notice. So if you could please take [event] to as read.

And then looking to Page #3, what we have here is looking at our growth over this time period, we've had on the top figure, 1H 2022. You can see we have $55 million of sales revenues from total operations, which is a 14% increase on the prior year. And looking down at the bottom graphs, we have operating profit on the left, and that shows we've got about 2.3x improvement in our half

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot